38095004|t|Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis.
38095004|a|Background: Direct-acting oral anticoagulants (DOACs) have demonstrated superior efficacy in preventing stroke and death compared with warfarin in patients with atrial fibrillation (AF), but their influence on dementia risk remains unclear. Objectives: The purpose of this study was to evaluate the relative risks of dementia in DOAC vs warfarin in patients with AF. Methods: An electronic literature search was conducted to retrieve studies reporting comparisons of dementia incidence between patients treated with DOACs and warfarin for AF. HRs and 95% CI were pooled in a random-effects meta-analysis. Meta-regression was performed to identify prognostic baseline variables. Network meta-analysis was performed to determine dementia risk between individual DOACs and warfarin. Results: Ten studies (n = 342,624) were retrieved. DOAC was associated with a significantly lower risk of developing dementia compared with warfarin (HR: 0.88; 95% CI: 0.80-0.98; P = 0.017; I2 = 75%); significance was also seen in Asian patients (HR: 0.81; 95% CI: 0.68-0.86) but not non-Asian patients. Subgroup analyses of propensity score-matched studies and patients aged 65-75 years showed similar significance, but not for patients aged >=75 years. Meta-regression found that a lower mean age corresponded to significantly greater favoring of DOAC over warfarin. Network meta-analysis found significant reductions in dementia risk over warfarin for rivaroxaban (HR: 0.854; 95% CI: 0.763-0.955), apixaban (HR: 0.881; 95% CI: 0.778-0.997), and dabigatran (HR: 0.871; 95% CI: 0.770-0.987); the highest-ranked treatment based on P scores was edoxaban. Conclusions: The use of DOAC in AF significantly reduces dementia risk compared with warfarin, particularly in Asian patients. The possible reversal of this effect with increasing age merits further randomized trials with long-term follow-up. (Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis; CRD42022365634).
38095004	0	8	Dementia	Disease	MESH:D003704
38095004	24	43	Oral Anticoagulants	Chemical	-
38095004	51	59	Warfarin	Chemical	MESH:D014859
38095004	64	83	Atrial Fibrillation	Disease	MESH:D001281
38095004	226	232	stroke	Disease	MESH:D020521
38095004	237	242	death	Disease	MESH:D003643
38095004	257	265	warfarin	Chemical	MESH:D014859
38095004	269	277	patients	Species	9606
38095004	283	302	atrial fibrillation	Disease	MESH:D001281
38095004	304	306	AF	Disease	MESH:D001281
38095004	332	340	dementia	Disease	MESH:D003704
38095004	439	447	dementia	Disease	MESH:D003704
38095004	459	467	warfarin	Chemical	MESH:D014859
38095004	471	479	patients	Species	9606
38095004	485	487	AF	Disease	MESH:D001281
38095004	589	597	dementia	Disease	MESH:D003704
38095004	616	624	patients	Species	9606
38095004	648	656	warfarin	Chemical	MESH:D014859
38095004	661	663	AF	Disease	MESH:D001281
38095004	849	857	dementia	Disease	MESH:D003704
38095004	892	900	warfarin	Chemical	MESH:D014859
38095004	1019	1027	dementia	Disease	MESH:D003704
38095004	1042	1050	warfarin	Chemical	MESH:D014859
38095004	1139	1147	patients	Species	9606
38095004	1196	1204	patients	Species	9606
38095004	1264	1272	patients	Species	9606
38095004	1331	1339	patients	Species	9606
38095004	1461	1469	warfarin	Chemical	MESH:D014859
38095004	1525	1533	dementia	Disease	MESH:D003704
38095004	1544	1552	warfarin	Chemical	MESH:D014859
38095004	1557	1568	rivaroxaban	Chemical	MESH:D000069552
38095004	1603	1611	apixaban	Chemical	MESH:C522181
38095004	1650	1660	dabigatran	Chemical	MESH:D000069604
38095004	1746	1754	edoxaban	Chemical	MESH:C552171
38095004	1788	1790	AF	Disease	MESH:D001281
38095004	1813	1821	dementia	Disease	MESH:D003704
38095004	1841	1849	warfarin	Chemical	MESH:D014859
38095004	1873	1881	patients	Species	9606
38095004	2000	2008	Dementia	Disease	MESH:D003704
38095004	2024	2043	Oral Anticoagulants	Chemical	-
38095004	2051	2059	Warfarin	Chemical	MESH:D014859
38095004	2064	2083	Atrial Fibrillation	Disease	MESH:D001281
38095004	Positive_Correlation	MESH:D014859	MESH:D003704
38095004	Negative_Correlation	MESH:D014859	MESH:D001281
38095004	Negative_Correlation	MESH:C522181	MESH:D003704
38095004	Negative_Correlation	MESH:D000069552	MESH:D003704
38095004	Negative_Correlation	MESH:D000069552	MESH:D001281
38095004	Negative_Correlation	MESH:D000069604	MESH:D003704
38095004	Negative_Correlation	MESH:C552171	MESH:D003704

